Trypanothione reductase and superoxide dismutase as current drug targets for Trypanosoma cruzi: an overview of compounds with activity against Chagas disease

I Beltran-Hortelano, S Perez-Silanes… - Current Medicinal …, 2017 - ingentaconnect.com
It has been over a century since Carlos Chagas discovered the Trypanosoma cruzi (T. cruzi)
as the causative agent of Chagas disease (CD), a neglected tropical disease with several …

Natural and synthetic naphthoquinones as potential anti-infective agents

E Ortiz-Pérez, G Rivera, CO Salas… - Current Topics in …, 2021 - ingentaconnect.com
Background: Naphthoquinones are a class of aromatic compounds relevant for their
chemical characteristics, structural properties, and biological activity. These compounds are …

Quantitative proteomics of Trypanosoma cruzi during metacyclogenesis

LMF de Godoy, FK Marchini, DP Pavoni… - …, 2012 - Wiley Online Library
Trypanosoma cruzi is the etiologic agent of Chagas disease, which is estimated to affect
over eight million people around the world. Trypanosoma cruzi has a complex life cycle …

Synthesis and biological evaluation of 1, 4-naphthoquinones and quinoline-5, 8-diones as antimalarial and schistosomicidal agents

DA Lanfranchi, E Cesar-Rodo, B Bertrand… - Organic & …, 2012 - pubs.rsc.org
Improving the solubility of polysubstituted 1, 4-naphthoquinone derivatives was achieved by
introducing nitrogen in two different positions of the naphthoquinone core, at C-5 and at C-8 …

Synthesis, characterization and biological activities of 3-aryl-1, 4-naphthoquinones–green palladium-catalysed Suzuki cross coupling

AR Louvis, NAA Silva, FS Semaan… - New Journal of …, 2016 - pubs.rsc.org
Quinones are important scaffolds that are present in a variety of natural products or synthetic
bioactive molecules. Arylation is an important strategy for accomplishing structural …

Synthetic medicinal chemistry in Chagas' disease: Compounds at the final stage of “hit-to-lead” phase

H Cerecetto, M González - Pharmaceuticals, 2010 - mdpi.com
Chagas' disease, or American trypanosomosiasis, has been the most relevant illness
produced by protozoa in Latin America. Synthetic medicinal chemistry efforts have provided …

Optimization of 1,4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against Trypanosoma cruzi

LS Lara, GC Lechuga, CS Moreira, TB Santos… - Molecules, 2021 - mdpi.com
Chagas disease (CD) still represents a serious public health problem in Latin America, even
after more than 100 years of its discovery. Clinical treatments (nifurtimox and benznidazole) …

Naphthoquinones and derivatives for chemotherapy: perspectives and limitations of their anti-trypanosomatids activities

L Dantas-Pereira, EF Cunha-Junior… - Current …, 2021 - ingentaconnect.com
Chagas disease, Sleeping sickness and Leishmaniasis, caused by trypanosomatids
Trypanosoma cruzi, Trypanosoma brucei and Leishmania spp., respectively, are considered …

Lipoamide dehydrogenase is essential for both bloodstream and procyclic Trypanosoma brucei

A Roldán, MA Comini, M Crispo… - Molecular …, 2011 - Wiley Online Library
Lipoamide dehydrogenase (LipDH) is a component of four mitochondrial multienzyme
complexes. RNA interference or the deletion of both alleles in bloodstream Trypanosoma …

Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs

BS Hall, EL Meredith, SR Wilkinson - Antimicrobial agents and …, 2012 - Am Soc Microbiol
Nitroheterocyclic prodrugs are used to treat infections caused by Trypanosoma cruzi and
Trypanosoma brucei. A key component in selectivity involves a specific activation step …